Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05480644 · ClinicalTrials.gov registry record
Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors
A clinical trial of Brain Metastases, Adult and Brain Tumor, Primary, sponsored by Duke University.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT05480644: Recruiting study of Brain Metastases, Adult and Brain Tumor, Primary, sponsored by Duke University.
NCT05480644 is a study of Brain Metastases, Adult and Brain Tumor, Primary that is actively recruiting participants, run by Duke University. The registered enrollment target is 300 participants, above the 75-participant average among 14 other Brain Metastases, Adult trials with a reported enrollment target (300% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05480644, a study of Brain Metastases, Adult and Brain Tumor, Primary, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this protocol is to create a repository of blood samples from patients diagnosed with primary and metastatic brain tumors who are being seen in the Department of Radiation Oncology at Duke Cancer Center.
Primary Outcome
reported as mean +/- standard deviation
Conditions Studied
Study Locations (1)
North Carolina
- Duke Cancer Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2022-12-01 |
| Est. Completion | 2032-12 |
What NCT05480644 shows while recruiting
NCT05480644 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 75-participant average among 14 other Brain Metastases, Adult trials with a reported enrollment target (300% higher).
The record links to 2 conditions, with Brain Metastases, Adult appearing as the primary indexed condition, and to 0 interventions.
NCT05480644 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05480644 about?
NCT05480644 is a clinical study titled "Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors". The purpose of this protocol is to create a repository of blood samples from patients diagnosed with primary and metastatic brain tumors who are being seen in the Department of Radiation Oncology at Duke Cancer Center.
What is the current status of trial NCT05480644?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2022-12-01. Estimated completion is 2032-12.
What conditions does trial NCT05480644 study?
This clinical trial studies the following conditions: Brain Metastases, Adult, Brain Tumor, Primary.
Who is sponsoring clinical trial NCT05480644?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05480644 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Metastases, Adult
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05480644's enrollment target sits among peer trials
300 1st of 14 higher than 14 of 14 other Brain Metastases, Adult trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Metastases, Adult trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
RECRUITING · Phase 1
-
Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery
RECRUITING · Phase 1
-
Multi-disciplinary Care for Brain Metastases
RECRUITING · NA
-
UCSD Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases
RECRUITING · Phase 2
-
Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases
RECRUITING · Phase 1
-
Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI